Anti-myeloma effects induced by myeloma idiotype pulsed dendritic cells in vitro.

被引：0
|
作者：
Zhang, M
Yin, XR
Luo, YY
Lin, X
He, PC
Wang, MC
Li, J
Liu, YL
Guo, GL
Cai, RB
Qiu, L
机构：
[1] Xian Jiaotong Univ, Affiliated Hosp 1, Xian 710049, Shaanxi, Peoples R China
[2] Inst Hematol, BMT Ctr, Tianjin, Hebei, Peoples R China
[3] Blood Dis Hosp, Tianjin, Hebei, Peoples R China
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5131
引用
收藏
页码：366B / 366B
页数：1
相关论文
共 50 条
  • [41] Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
    Chakraborty, Rajshekhar
    Rybicki, Lisa
    Valent, Jason
    Garcia, Alex V. Mejia
    Faiman, Beth M.
    Khouri, Jack
    Samaras, Christy J.
    Anwer, Faiz
    Khorana, Alok A.
    [J]. BLOOD CANCER JOURNAL, 2021, 11 (06)
  • [42] Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
    Rajshekhar Chakraborty
    Lisa Rybicki
    Jason Valent
    Alex V. Mejia Garcia
    Beth M. Faiman
    Jack Khouri
    Christy J. Samaras
    Faiz Anwer
    Alok A. Khorana
    [J]. Blood Cancer Journal, 11
  • [43] In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma
    Burjanadze, Maka
    Condomines, Maud
    Reme, Thierry
    Quittet, Philippe
    Latry, Pascal
    Lugagne, Cecile
    Romagne, Francois
    Morel, Yanis
    Rossi, Jean Francois
    Klein, Bernard
    Lu, Zhao Yang
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (02) : 206 - 216
  • [44] Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after coculture with idiotype-pulsed dendritic cells.
    Märten, A
    Renoth, S
    von Lilienfeld-Toal, M
    Buttgereit, P
    Schakowski, F
    Schmidt-Wolf, IGH
    [J]. BLOOD, 2001, 98 (11) : 300B - 300B
  • [45] Anti-Myeloma Effects of the Selective JAK1 Inhibitor INCB052793 in Combination with Active Myeloma Agents In Vitro and In Vivo
    Sanchez, Eric
    Porter, Autumn
    Li, Mingjie
    Wang, Cathy
    Smith, Emily
    Soof, Camilia
    Director, Chelsea
    Tang, George
    Chen, Haiming
    Berenson, James
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E49 - E50
  • [46] Acid overcomes drug resistance in myeloma and significantly increases the anti-myeloma effects of both arsenic trioxide and melphalan in vitro and in vivo.
    Campbell, RA
    Chen, HM
    Zhu, DC
    Santos, JC
    Bonavida, B
    Pang, S
    Said, J
    Berenson, JR
    [J]. BLOOD, 2004, 104 (11) : 678A - 678A
  • [47] POMALIDOMIDE ENHANCES THE ACTIVATION OF ANTI-MYELOMA SPECIFIC T CELLS IN HEALTHY DONORS AND MULTIPLE MYELOMA PATIENTS
    Dai, J.
    Neuber, B.
    Engelhardt, M.
    Medenhoff, S.
    Schmitt, M.
    Ho, A. D.
    Goldschmidt, H.
    Hundemer, M.
    [J]. HAEMATOLOGICA, 2015, 100 : 78 - 78
  • [48] Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma
    Guardino, AE
    Rajapaksa, R
    Ong, KH
    Sheehan, K
    Levy, R
    [J]. CYTOTHERAPY, 2006, 8 (03) : 277 - 289
  • [49] Targeting ubiquitin-specific protease-7 in plasmacytoid dendritic cells triggers anti-myeloma immunity
    Arghya Ray
    Ting Du
    Yan Song
    Sara J. Buhrlage
    Dharminder Chauhan
    Kenneth C. Anderson
    [J]. Leukemia, 2021, 35 : 2435 - 2438
  • [50] Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells
    Stefka, A. T.
    Park, J-H
    Matsuo, Y.
    Chung, S.
    Nakamura, Y.
    Jakubowiak, A. J.
    Rosebeck, S.
    [J]. BLOOD CANCER JOURNAL, 2016, 6 : e460 - e460
12345